Victory Capital Management Inc. Lowers Stock Position in Patterson Companies, Inc. (NASDAQ:PDCO)

Victory Capital Management Inc. lowered its position in Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 4.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 365,436 shares of the company's stock after selling 18,513 shares during the period. Victory Capital Management Inc. owned about 0.41% of Patterson Companies worth $11,277,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. GAMMA Investing LLC grew its stake in Patterson Companies by 103.0% in the 4th quarter. GAMMA Investing LLC now owns 1,340 shares of the company's stock valued at $41,000 after purchasing an additional 680 shares during the period. Anchor Investment Management LLC boosted its holdings in shares of Patterson Companies by 20.5% in the 3rd quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock worth $51,000 after buying an additional 400 shares during the last quarter. KBC Group NV grew its position in Patterson Companies by 32.7% during the third quarter. KBC Group NV now owns 2,757 shares of the company's stock valued at $60,000 after buying an additional 680 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in Patterson Companies during the third quarter worth about $65,000. Finally, Blue Trust Inc. raised its position in Patterson Companies by 18.0% in the fourth quarter. Blue Trust Inc. now owns 2,738 shares of the company's stock worth $84,000 after acquiring an additional 417 shares during the period. 85.43% of the stock is owned by institutional investors.

Patterson Companies Price Performance

Patterson Companies stock traded up $0.04 during midday trading on Monday, reaching $31.18. 511,853 shares of the stock were exchanged, compared to its average volume of 1,012,486. Patterson Companies, Inc. has a 52 week low of $19.45 and a 52 week high of $31.79. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The firm has a market cap of $2.76 billion, a PE ratio of 18.23, a PEG ratio of 2.71 and a beta of 0.99. The company's fifty day moving average is $31.01 and its 200-day moving average is $25.92.

Remove Ads

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on PDCO. Mizuho started coverage on shares of Patterson Companies in a research report on Wednesday, December 4th. They set a "neutral" rating and a $23.00 target price for the company. Morgan Stanley increased their price target on Patterson Companies from $27.00 to $31.35 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Piper Sandler lowered their price objective on Patterson Companies from $26.00 to $24.00 and set a "neutral" rating on the stock in a research note on Friday, December 6th. StockNews.com started coverage on shares of Patterson Companies in a research report on Tuesday, March 11th. They set a "hold" rating for the company. Finally, Leerink Partnrs downgraded shares of Patterson Companies from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Eleven analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $26.57.

Patterson Companies Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.